Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ad.2019.11.013 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Effectiveness of Topical Treatment for Plantar Warts: A Retrospective Cohort Study.
Infect Dis Rep
November 2024
Department of Podiatry of the Faculty of Nursing, Physiotherapy and Podiatry of the University of Seville, Calle Avicena s/n, 41009 Seville, Spain.
: Plantar warts, caused by human papillomavirus (HPV), are a common condition that can be painful and resistant to treatment. There are various therapeutic options for managing them, but it is not always clear which are the most effective and tolerated by patients. Among the most commonly used treatments are a zinc and nitric complex (nitrizinc complex), cantharidin, and bleomycin, each with different mechanisms of action and profiles in terms of pain and patient satisfaction.
View Article and Find Full Text PDFCantharidin (1%), podophyllin (5%), and salicylic acid (30%) formulation in recalcitrant plantar warts: Analysis of 48 patients.
J Med Virol
September 2024
Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), University Podiatric Clinic, Complutense University of Madrid, Madrid, Spain.
A plantar wart is a benign hyperplasia that appears on the feet due to the human papillomavirus (HPV). One method used for the treatment of recalcitrant plantar warts, those lasting over 2 years or persisting after at least two treatment attempts, is the cantharidin (1%), podophyllin (5%), and salicylic acid (30%) formulation, also known as the CPS formulation. Although this method is in use, there are few studies on it.
View Article and Find Full Text PDFCantharidin overcomes IL-2Rα signaling-mediated vorinostat resistance in cutaneous T-cell lymphoma through reactive oxygen species.
J Immunother Cancer
July 2024
Department of Dermatology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
Background: Vorinostat (SAHA) is a histone deacetylase inhibitor that has shown clinical efficacy against advanced cutaneous T-cell lymphoma (CTCL). However, only a subset of patients with CTCL (30-35%) respond to SAHA and the response is not always sustainable. Thus, understanding the mechanisms underlying evasive resistance in this cancer is an unmet medical need to improve the efficacy of current therapies.
View Article and Find Full Text PDF[Discrimination of anti-tumor and cardioprotective effect quality markers from Aidi Injection based on "spider web" mode].
Zhongguo Zhong Yao Za Zhi
April 2024
Guizhou Provincial Key Laboratory of Pharmaceutics, State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University Guiyang 550004, China National Engineering Research Center of Miao's Medicines Guiyang 550004, China.
Chinese medicinal preparations play an equally important role in reducing toxicity and treating tumors. Few studies discriminate the quality markers(Q-markers) conferring different therapeutic effects of traditional Chinese medicine preparations. Therefore, we take Aidi Injection(AD) as an example to comprehensively identify the Q-markers of anti-tumor and cardioprotective effects based on the "spider web" mode.
View Article and Find Full Text PDFNorcantharidin in cancer therapy - a new approach to overcoming therapeutic resistance: A review.
Medicine (Baltimore)
March 2024
Department of Oncology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
Therapeutic resistance in cancer remains a dilemma that scientists and oncologists are eager to solve. Despite several preclinical and clinical studies dedicated to overcoming therapeutic resistance, they often do not yield the expected outcomes. This is primarily due to the multifactorial phenomenon of therapeutic resistance.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!